TVTX Earnings

Quarterly EPS
$-0.70
Q3 2024
$-0.72
Q4 2024
$-0.47
Q1 2025
$-0.14
Q2 2025
$0.29
Q3 2025
$0.03
Q4 2025
$-0.40
Q1 2026
$-0.37
Q2 2026
Latest Revenue169.6M
Latest Net Income-34797000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.37169.6M-34797000+48.2%-164.3%
Q1 2026-$0.40127.2M-37102000+55.6%+14.9%
Q4 2025$0.03129.7M2.7M+73.4%+104.2%
Q3 2025$0.29164.9M25.7M+162.1%+141.4%
Q2 2025-$0.14114.4M-12755000+111.5%+84.6%
Q1 2025-$0.4781.7M-41226000+97.5%+73.3%
Q4 2024-$0.7274.8M-60264000+66.0%+39.0%
Q3 2024-$0.7062.9M-54811000+69.6%-135.5%
Q2 2024-$0.9154.1M-70409000
Q1 2024-$1.7641.4M-136061000
Q4 2023-$1.1845.1M-90173000
Q3 2023$1.9737.1M150.7M
Travere Therapeutics (TVTX) — Earnings